A Pedometer-Guided Physical Activity Intervention for Obese Pregnant Women (the Fit MUM Study): Randomized Feasibility Study.


Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
26 05 2020
Historique:
received: 20 06 2019
accepted: 12 02 2020
revised: 23 11 2019
pubmed: 30 4 2020
medline: 10 3 2021
entrez: 30 4 2020
Statut: epublish

Résumé

Obesity in pregnancy is a growing problem worldwide, with excessive gestational weight gain (GWG) occurring in the majority of pregnancies. This significantly increases risks to both mother and child. A major contributor to both prepregnancy obesity and excessive GWG is physical inactivity; however, past interventions targeting maternal weight gain and activity levels during the antenatal period have been ineffective in women who are already overweight. Pedometer-guided activity may offer a novel solution for increasing activity levels in this population. This initial feasibility randomized controlled trial aimed to test a pedometer-based intervention to increase activity and reduce excessive GWG in pregnant women. We supplied 30 pregnant women with obesity a Fitbit Zip pedometer and randomized them into 1 of 3 groups: control (pedometer only), app (pedometer synced to patients' personal smartphone, with self-monitoring of activity), or app-coach (addition of a health coach-delivered behavioral change program). Feasibility outcomes included participant compliance with wearing pedometers (days with missing pedometer data), data syncing, and data integrity. Activity outcomes (step counts and active minutes) were analyzed using linear mixed models and generalized estimating equations. A total of 30 participants were recruited within a 10-week period, with a dropout rate of 10% (3/30; 2 withdrawals and 1 stillbirth); 27 participants thus completed the study. Mean BMI in all groups was ≥35 kg/m Activity data syncing with a personal smartphone is feasible in a cohort of pregnant women with obesity. However, our results do not support a future definitive study in its present form. Recruitment and retention rates were adequate, as was activity data syncing to participants' smartphones. A follow-up interventional trial seeking to reduce GWG and improve activity in this population must focus on improving compliance with activity data recording and behavioral interventions delivered. Australian and New Zealand Clinical Trials Registry ACTRN12617000038392; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=370884.

Sections du résumé

BACKGROUND
Obesity in pregnancy is a growing problem worldwide, with excessive gestational weight gain (GWG) occurring in the majority of pregnancies. This significantly increases risks to both mother and child. A major contributor to both prepregnancy obesity and excessive GWG is physical inactivity; however, past interventions targeting maternal weight gain and activity levels during the antenatal period have been ineffective in women who are already overweight. Pedometer-guided activity may offer a novel solution for increasing activity levels in this population.
OBJECTIVE
This initial feasibility randomized controlled trial aimed to test a pedometer-based intervention to increase activity and reduce excessive GWG in pregnant women.
METHODS
We supplied 30 pregnant women with obesity a Fitbit Zip pedometer and randomized them into 1 of 3 groups: control (pedometer only), app (pedometer synced to patients' personal smartphone, with self-monitoring of activity), or app-coach (addition of a health coach-delivered behavioral change program). Feasibility outcomes included participant compliance with wearing pedometers (days with missing pedometer data), data syncing, and data integrity. Activity outcomes (step counts and active minutes) were analyzed using linear mixed models and generalized estimating equations.
RESULTS
A total of 30 participants were recruited within a 10-week period, with a dropout rate of 10% (3/30; 2 withdrawals and 1 stillbirth); 27 participants thus completed the study. Mean BMI in all groups was ≥35 kg/m
CONCLUSIONS
Activity data syncing with a personal smartphone is feasible in a cohort of pregnant women with obesity. However, our results do not support a future definitive study in its present form. Recruitment and retention rates were adequate, as was activity data syncing to participants' smartphones. A follow-up interventional trial seeking to reduce GWG and improve activity in this population must focus on improving compliance with activity data recording and behavioral interventions delivered.
TRIAL REGISTRATION
Australian and New Zealand Clinical Trials Registry ACTRN12617000038392; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=370884.

Identifiants

pubmed: 32348280
pii: v8i5e15112
doi: 10.2196/15112
pmc: PMC7284400
doi:

Banques de données

ANZCTR
['ACTRN12617000038392']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15112

Informations de copyright

©Jai N Darvall, Andrew Wang, Mohamed Nusry Nazeem, Cheryce L Harrison, Lauren Clarke, Chennelle Mendoza, Anna Parker, Benjamin Harrap, Glyn Teale, David Story, Elizabeth Hessian. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 26.05.2020.

Références

Int J Behav Nutr Phys Act. 2014 Oct 31;11:134
pubmed: 25358909
JMIR Mhealth Uhealth. 2018 Aug 09;6(8):e10527
pubmed: 30093371
Matern Child Health J. 2016 Jun;20(6):1247-57
pubmed: 26955997
Sports Med. 2004;34(1):1-8
pubmed: 14715035
Am Psychol. 2000 Jan;55(1):68-78
pubmed: 11392867
Scand J Med Sci Sports. 2018 Jul;28(7):1818-1827
pubmed: 29460319
Sports Med Open. 2018 Sep 3;4(1):42
pubmed: 30178072
J Obstet Gynaecol. 2012 Jul;32(5):430-3
pubmed: 22663312
Anaesth Intensive Care. 2016 Jul;44(4):501-6
pubmed: 27456182
Cochrane Database Syst Rev. 2015 Jun 15;(6):CD007145
pubmed: 26068707
BJOG. 2010 Oct;117(11):1316-26
pubmed: 20353459
JMIR Mhealth Uhealth. 2019 Jan 09;7(1):e10418
pubmed: 30626569
Obstet Gynecol. 2007 Oct;110(4):759-64
pubmed: 17906006
Int J Behav Nutr Phys Act. 2011 Mar 21;8:19
pubmed: 21418609
Am Psychol. 2002 Sep;57(9):705-17
pubmed: 12237980
Med J Aust. 2006 Jan 16;184(2):56-9
pubmed: 16411868
Acta Obstet Gynecol Scand. 2010 Jul;89(7):956-61
pubmed: 20583938
Int J Behav Nutr Phys Act. 2012 Feb 09;9:12
pubmed: 22321640
Am J Obstet Gynecol. 2014 Feb;210(2):134.e1-9
pubmed: 24060449
JAMA. 2017 Jun 6;317(21):2207-2225
pubmed: 28586887
Semin Reprod Med. 2016 Mar;34(2):e28-37
pubmed: 27169984
Med J Aust. 2012 Feb 20;196(3):184-8
pubmed: 22339524

Auteurs

Jai N Darvall (JN)

Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Melbourne, Australia.
Centre for Integrated Critical Care, University of Melbourne, Melbourne, Australia.

Andrew Wang (A)

Melbourne Medical School, University of Melbourne, Melbourne, Australia.

Mohamed Nusry Nazeem (MN)

Melbourne Medical School, University of Melbourne, Melbourne, Australia.

Cheryce L Harrison (CL)

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Lauren Clarke (L)

Department of Physiotherapy, Western Health, Melbourne, Australia.

Chennelle Mendoza (C)

Department of Physiotherapy, Western Health, Melbourne, Australia.

Anna Parker (A)

Centre for Integrated Critical Care, University of Melbourne, Melbourne, Australia.

Benjamin Harrap (B)

Melbourne Epicentre, University of Melbourne, Melbourne, Australia.

Glyn Teale (G)

Department of Women's and Children's Services, Western Health, Melbourne, Australia.

David Story (D)

Centre for Integrated Critical Care, University of Melbourne, Melbourne, Australia.

Elizabeth Hessian (E)

Department of Anaesthesia and Pain Management, Western Health, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH